MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$10,786,594
EPS
-$0.27
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
3,941,932
7,935,680
6,819,083.5*
9,357,444
General and administrative
3,869,371
4,738,686
4,081,793*
3,907,090
Change in estimate for legal contingencies
-
-
0*
-
Income from insurance recovery
-
-
0*
-
Change in estimate for legal contingency
3,250,000
-
-
0
Total operating expenses
11,061,303
12,674,366
10,900,876.5
13,264,534
Operating loss
-11,061,303
-12,674,366
-10,900,876.5*
-13,264,534
Interest expense
3,299
2,199
0*
0
Interest and other income, net
103,208
169,615
456,557*
418,474
Gains from asset sales
178,200
-
89,605.5*
91,400
Other expense
0
-2,411
-502*
0
Total other (income) expense, net
278,109
165,005
545,660.5*
509,874
Loss before income taxes
-10,783,194
-12,509,361
-10,355,216*
-12,754,660
Provision for income taxes
3,400
0
300*
0
Net loss
-10,786,594
-12,509,361
-10,355,516
-12,754,660
Basic EPS
-0.27
-0.32
-0.261
-0.32
Diluted EPS
-0.27
-0.32
-0.261
-0.32
Basic Average Shares
39,694,243
39,681,465
39,662,799
39,665,927
Diluted Average Shares
39,694,243
39,681,465
39,662,799
39,665,927
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$10,786,594
(38.80%↑ Y/Y)
Gains from asset sales
$178,200
(99.41%↑ Y/Y)
Interest and other
income, net
$103,208
(-80.64%↓ Y/Y)
Loss before income
taxes
-$10,783,194
(38.81%↑ Y/Y)
Provision for income taxes
$3,400
(0.00%↑ Y/Y)
Total other (income)
expense, net
$278,109
(-55.32%↓ Y/Y)
Interest expense
$3,299
Operating loss
-$11,061,303
(39.37%↑ Y/Y)
Total operating
expenses
$11,061,303
(-39.37%↓ Y/Y)
Research and development
$3,941,932
(-72.51%↓ Y/Y)
General and
administrative
$3,869,371
(-0.94%↓ Y/Y)
Change in estimate for
legal contingency
$3,250,000
Buy us a coffee
Skye Bioscience, Inc. (SKYE)
Skye Bioscience, Inc. (SKYE)